- Global Pharma News & Resources

The Galien Foundation Announces 2018 #PrixGalien Award Recipients

The Galien Foundation Announces 2018 #PrixGalien Award Recipients Work spans gender equity to advances in non-Hodgkin lymphoma; leukemia; and atrial fibrillation

PR Newswire

NEW YORK, Oct. 26, 2018

NEW YORK, Oct. 26, 2018 /PRNewswire/ -- The Prix Galien USA Committee last night honored excellence in the biopharmaceutical and medical industry for research, development and innovation at its 12th annual Prix Galien Awards Gala, held at the American Museum of Natural History in New York City. In recognition of the development and discovery of products that improve the human condition, a committee of highly accomplished scientific leaders, inclusive of four Novel Laureates, recognized winners in three categories: "Best Pharmaceutical Product," "Best Biotechnology Product," and "Best Medical Technology." This year, the Committee has chosen two winners in the Biotechnology category.

2018 Prix Galien USA Award Winners

"Best Pharmaceutical Product"



"Best Biotechnology Product"

Kite a Gilead Company


Novartis Pharmaceuticals Corporation


"Best Medical Technology"

Boston Scientific Corporation


"The Committee had the unique opportunity to award four winners across three categories due to the extremely high caliber of scientific rigor demonstrated by this year's candidates," said Bruno Cohen, Chairman of the Galien Foundation. "All winners have made crucial contributions to the advancement of scientific understanding and improved outcomes for humankind. We are proud to honor their tireless work and unrelenting spirit."

In addition to the 2018 product innovation awards, this year's Roy Vagelos Pro Bono Humanum Award was accepted by Bill and Melinda Gates, co-chairs of the Bill & Melinda Gates Foundation. Widely recognized as champions of the world's most economically disadvantaged individuals, Bill and Melinda Gates were selected by the Committee for their impressive humanitarian efforts and advocacy for gender equity.

"I have been privileged to work with Bill and Melinda Gates for the past four years. They are guided by a simple principle: all lives have equal value. They not only believe this, but put this into practice around the world," said Dr. Sue Desmond-Hellmann, Chief Executive Officer of the Bill & Melinda Gates Foundation and Chair of the Prix Galien USA. "I can confidently say that their generosity, hard work, and strength of purpose are helping make our world a better place."

About The Galien Foundation

The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives.

The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. The Prix Galien was created in France in 1970 in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical and medical technology research.

For more information, visit

Follow the Foundation on social media:

Media Contact:
Giana Gregga
Finn Partners

View original content to download multimedia:

SOURCE The Galien Foundation

Editor Details

Last Updated: 26-Oct-2018